Obstructive Sleep Apnea Osa Epidemiology Forecast

DelveInsight's 'Obstructive Sleep Apnea (OSA) - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Obstructive Sleep Apnea (OSA) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Obstructive Sleep Apnea (OSA) Understanding

The DelveInsight Obstructive Sleep Apnea (OSA) epidemiology report gives a thorough understanding of the Obstructive Sleep Apnea (OSA) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Obstructive Sleep Apnea (OSA) in the US, Europe, and Japan. The report covers the detailed information of the Obstructive Sleep Apnea (OSA) epidemiology scenario in seven major countries (US, EU5, and Japan).


Obstructive Sleep Apnea (OSA) Epidemiology Perspective by DelveInsight

The Obstructive Sleep Apnea (OSA) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Obstructive Sleep Apnea (OSA) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Obstructive Sleep Apnea (OSA) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Obstructive Sleep Apnea (OSA) Detailed Epidemiology Segmentation

The Obstructive Sleep Apnea (OSA) epidemiology covered in the report provides historical as well as forecasted Obstructive Sleep Apnea (OSA) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.


The DelveInsight Obstructive Sleep Apnea (OSA) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The Obstructive Sleep Apnea (OSA) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Obstructive Sleep Apnea (OSA) Epidemiology Report and Model provide an overview of the risk factors and global trends of Obstructive Sleep Apnea (OSA) in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Obstructive Sleep Apnea (OSA) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Obstructive Sleep Apnea (OSA)
  • The report provides the segmentation of the Obstructive Sleep Apnea (OSA) epidemiology


Report Highlights

  • 11-Year Forecast of Obstructive Sleep Apnea (OSA) epidemiology
  • 7MM Coverage
  • Total Cases of Obstructive Sleep Apnea (OSA)
  • Total Cases of Obstructive Sleep Apnea (OSA) according to segmentation
  • Diagnosed cases of Obstructive Sleep Apnea (OSA)


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Obstructive Sleep Apnea (OSA)?
  • What are the key findings pertaining to the Obstructive Sleep Apnea (OSA) epidemiology across 7MM and which country will have the h
  • ighest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Obstructive Sleep Apnea (OSA) across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Obstructive Sleep Apnea (OSA)?
  • What are the currently available treatments of Obstructive Sleep Apnea (OSA)?


Reasons to buy

  • The Obstructive Sleep Apnea (OSA) Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Obstructive Sleep Apnea (OSA) market
  • Quantify patient populations in the global Obstructive Sleep Apnea (OSA) market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Obstructive Sleep Apnea (OSA) therapeutics in each of the markets covered
  • Understand the magnitude of Obstructive Sleep Apnea (OSA) population by its epidemiology
  • The Obstructive Sleep Apnea (OSA) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights

2. Executive Summary of Obstructive Sleep Apnea

3. SWOT Analysis for OSA

4. Disease Background and Overview

4.1. Introduction

4.2. Etiology

4.3. Severity Based Classification

4.4. Clinical Manifestations of Obstructive Sleep Apnea

4.5. Symptoms

4.6. Pathophysiology

4.7. Risk factors

4.8. Diagnosis

5. Epidemiology and Patient Population

5.1. Key Findings

6. 7MM Epidemiology

6.1. Assumptions and rationale

6.2. Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in 7MM

6.3. United States

6.3.1. Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in the United States

6.3.2. Gender-specific cases of Obstructive Sleep Apnea (OSA) in the United States

6.3.3. Age-specific cases of Obstructive Sleep Apnea (OSA) in the United States

6.3.4. Severity-specific cases of Obstructive Sleep Apnea (OSA) in the United States

6.4. Germany

6.4.1. Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in Germany

6.4.2. Gender-specific cases of Obstructive Sleep Apnea (OSA) in Germany

6.4.3. Age-specific cases of Obstructive Sleep Apnea (OSA) in Germany

6.4.4. Severity-specific cases of Obstructive Sleep Apnea (OSA) in Germany

6.5. France

6.5.1. Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in France

6.5.2. Gender-specific cases of Obstructive Sleep Apnea (OSA) in France

6.5.3. Age-specific cases of Obstructive Sleep Apnea (OSA) in France

6.5.4. Severity-specific cases of Obstructive Sleep Apnea (OSA) in France

6.6. Italy

6.6.1. Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in Italy

6.6.2. Gender-specific cases of Obstructive Sleep Apnea (OSA) in Italy

6.6.3. Age-specific cases of Obstructive Sleep Apnea (OSA) in Italy

6.6.4. Severity-specific cases of Obstructive Sleep Apnea (OSA) in Italy

6.7. Spain

6.7.1. Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in Spain

6.7.2. Gender-specific cases of Obstructive Sleep Apnea (OSA) in Spain

6.7.3. Age-specific cases of Obstructive Sleep Apnea (OSA) in Spain

6.7.4. Severity-specific cases of Obstructive Sleep Apnea (OSA) in Spain

6.8. United Kingdom

6.8.1. Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in the United Kingdom

6.8.2. Gender-specific cases of Obstructive Sleep Apnea (OSA) in the United Kingdom

6.8.3. Age-specific cases of Obstructive Sleep Apnea (OSA) in the United Kingdom

6.8.4. Severity-specific cases of Obstructive Sleep Apnea (OSA) in the United Kingdom

6.9. Japan

6.9.1. Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in Japan

6.9.2. Gender-specific cases of Obstructive Sleep Apnea (OSA) in Japan

6.9.3. Age-specific cases of Obstructive Sleep Apnea (OSA) in Japan

6.9.4. Severity-specific cases of Obstructive Sleep Apnea (OSA) in Japan

7. Treatment

8. Unmet Needs

9. Organizations contributing toward OSA

10. Case Study

10.1. Case Study: Imaging of Apnea Termination in a Patient with Obstructive Sleep Apnea during Natural Sleep

10.2. Treatment of Comorbid Obstructive Sleep Apnea by Upper Airway Stimulation Results in Resolution of Debilitating Symptoms of Restless Legs Syndrome

10.3. Obstructive sleep apnea caused by acromegaly: A case report

10.4. Case Study: Sleep Apnea Diagnosis in a Man with Type 2 Diabetes Improved Control

11. Patient Journey

12. KOL Views

13. Appendix

13.1. Report Methodology

13.2. References

14. DelveInsight Capabilities

15. Disclaimer

16. About DelveInsight

List of Tables

Table 1 Summary of Obstructive Sleep Apnea Market, Epidemiology, and Key Events (2017–2030)

Table 2 Total diagnosed prevalent cases of Obstructive Sleep Apnea (OSA) in 7MM (2017–2030)

Table 3  Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in the United States (2017–2030)

Table 4 Gender-specific cases of Obstructive Sleep Apnea (OSA) in the US (2017–2030)

Table 5 Age-specific cases of Obstructive Sleep Apnea (OSA) in the US (2017–2030)

Table 6 Severity-specific cases of Obstructive Sleep Apnea (OSA) in the US (2017–2030)

Table 7 Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in Germany (2017–2030)

Table 8 Gender-specific cases of Obstructive Sleep Apnea (OSA) in Germany (2017–2030)

Table 9 Age-specific cases of Obstructive Sleep Apnea (OSA) in Germany (2017–2030)

Table 10 Severity-specific cases of Obstructive Sleep Apnea (OSA) in Germany (2017–2030)

Table 11  Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in France (2017–2030)

Table 12 Gender-specific cases of Obstructive Sleep Apnea (OSA) in France (2017–2030)

Table 13 Age-specific cases of Obstructive Sleep Apnea (OSA) in France (2017–2030)

Table 14 Severity-specific cases of Obstructive Sleep Apnea (OSA) in France (2017–2030)

Table 15 Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in Italy (2017–2030)

Table 16 Gender-specific cases of Obstructive Sleep Apnea (OSA) in Italy (2017–2030)

Table 17 Age-specific cases of Obstructive Sleep Apnea (OSA) in Italy (2017–2030)

Table 18 Severity-specific cases of Obstructive Sleep Apnea (OSA) in Italy (2017–2030)

Table 19 Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in Spain (2017–2030)

Table 20 Gender-specific cases of Obstructive Sleep Apnea (OSA) in Spain (2017–2030)

Table 21 Age-specific cases of Obstructive Sleep Apnea (OSA) in the US (2017–2030)

Table 22 Severity-specific cases of Obstructive Sleep Apnea (OSA) in Spain (2017–2030)

Table 23 Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in the United Kingdom (2017–2030)

Table 24 Gender-specific cases of Obstructive Sleep Apnea (OSA) in the UK (2017–2030)

Table 25 Age-specific cases of Obstructive Sleep Apnea (OSA) in the UK (2017–2030)

Table 26 Severity-specific cases of Obstructive Sleep Apnea (OSA) in the UK (2017–2030)

Table 27 Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in Japan (2017–2030)

Table 28 Gender-specific cases of Obstructive Sleep Apnea (OSA) in Japan (2017–2030)

Table 29 Age-specific cases of Obstructive Sleep Apnea (OSA) in Japan (2017–2030)

Table 30 Severity-specific cases of Obstructive Sleep Apnea (OSA) in Japan (2017–2030)

Table 31 Components of Patient Education Programs

Table 32  OSA Symptoms that Should Be Evaluated during a Comprehensive Sleep Evaluation

List of Figures

Figure 1 Pathological relationship between sleep apnea and cardiovascular disease

Figure 2 Schematic representation of the typical pathophysiological sequence that occurs in obstructive sleep apnea (OSA)

Figure 3 Schematic representation of the possible sites where each of the various pathophysiological traits would either predispose or tend to worsen OSA

Figure 4 A diagram to illustrate the risk factors for OSA

Figure 5 Clinical algorithm for implementation of clinical practice guidelines

Figure 6 Total diagnosed prevalent cases of Obstructive Sleep Apnea (OSA) in 7MM (2017–2030)

Figure 7 Total Diagnosed Prevalent Cases of OSA in the United States (2017–2030)

Figure 8 Gender-Specific cases of Obstructive Sleep Apnea (OSA) in the US (2017–2030)

Figure 9 Age-specific cases of Obstructive Sleep Apnea (OSA) in the US (2017–2030)

Figure 10 Severity-specific cases of Obstructive Sleep Apnea (OSA) in the US (2017–2030)

Figure 11 Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in Germany (2017–2030)

Figure 12 Gender-specific cases of Obstructive Sleep Apnea (OSA) in Germany (2017–2030)

Figure 13 Age-specific cases of Obstructive Sleep Apnea (OSA) in Germany (2017–2030)

Figure 14 Severity-specific cases of Obstructive Sleep Apnea (OSA) in Germany (2017–2030)

Figure 15 Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in France (2017–2030)

Figure 16 Gender-specific cases of Obstructive Sleep Apnea (OSA) in France (2017–2030)

Figure 17 Age-specific cases of Obstructive Sleep Apnea (OSA) in France (2017–2030)

Figure 18 Severity-specific cases of Obstructive Sleep Apnea (OSA) in France (2017–2030)

Figure 19 Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in Italy (2017–2030)

Figure 20 Gender-specific cases of Obstructive Sleep Apnea (OSA) in Italy (2017–2030)

Figure 21 Age-specific cases of Obstructive Sleep Apnea (OSA) in Italy (2017–2030)

Figure 22 Severity-specific cases of Obstructive Sleep Apnea (OSA) in Italy (2017–2030)

Figure 23 Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in Spain (2017–2030)

Figure 24 Gender-specific cases of Obstructive Sleep Apnea (OSA) in Spain (2017–2030)

Figure 25 Age-specific cases of Obstructive Sleep Apnea (OSA) in Spain (2017–2030)

Figure 26 Severity-specific cases of Obstructive Sleep Apnea (OSA) in Spain (2017–2030)

Figure 27 Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in the UK (2017–2030)

Figure 28 Gender-specific cases of Obstructive Sleep Apnea (OSA) in the UK (2017–2030)

Figure 29 Age-specific cases of Obstructive Sleep Apnea (OSA) in the UK (2017–2030)

Figure 30 Severity-specific cases of Obstructive Sleep Apnea (OSA) in the UK (2017–2030)

Figure 31 Total Diagnosed Prevalent cases of Obstructive Sleep Apnea (OSA) in Japan (2017–2030)

Figure 32 Gender-specific cases of Obstructive Sleep Apnea (OSA) in Japan (2017–2030)

Figure 33 Age-specific cases of Obstructive Sleep Apnea (OSA) in Japan (2017–2030)

Figure 34 Severity-specific cases of Obstructive Sleep Apnea (OSA) in Japan (2017–2030)

Figure 35 CPAP Treatment. Approach to the initiation, management, and follow-up of CPAP

Figure 36 Behavioral Treatment. Approach to the initiation, management, and follow-up of behavioral treatment

Figure 37 Surgical Treatment. Approach to the management of OSA with surgical therapy

Figure 38 Adjunctive Treatment. Approach to the management of OSA with adjunctive therapies

Figure 39 Unmet Needs of OSA

  • Tags:
  • Obstructive Sleep Apnea (OSA) Epide...
  • Obstructive Sleep Apnea (OSA)
  • Obstructive Sleep Apnea (OSA) Pipe...
  • Obstructive Sleep Apnea (OSA) Comp...
  • Obstructive Sleep Apnea (OSA) prev...
  • Obstructive Sleep Apnea (OSA) inci...
  • Obstructive Sleep Apnea (OSA) pati...
  • Obstructive Sleep Apnea (OSA) trea...

Forward to Friend

Need A Quote